BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 18624682)

  • 21. Pharmacokinetics of tazarotene and acitretin in psoriasis.
    Heath MS; Sahni DR; Curry ZA; Feldman SR
    Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):919-927. PubMed ID: 30134735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of calcipotriol + acitretin combination therapy for psoriasis: comparison with acitretin monotherapy.
    Rim JH; Park JY; Choe YB; Youn JI
    Am J Clin Dermatol; 2003; 4(7):507-10. PubMed ID: 12814339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acitretin-induced alopecia areata: a case report.
    Ozlu E; Karadag AS; Akdeniz N; Uzuncakmak TK
    Cutan Ocul Toxicol; 2015; 34(3):248-50. PubMed ID: 25198403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of psoriasis with retinoids: present status.
    Orfanos CE
    Cutis; 1999 Nov; 64(5):347-53. PubMed ID: 10582161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness and Safety of Acitretin in Children with Plaque Psoriasis: A Multicenter Retrospective Analysis.
    Di Lernia V; Bonamonte D; Lasagni C; Belloni Fortina A; Cambiaghi S; Corazza M; Di Nuzzo S; Gisondi P; Panzone M; Guarneri C; Neri I
    Pediatr Dermatol; 2016 Sep; 33(5):530-5. PubMed ID: 27443789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New roles for systemic retinoids.
    Lebwohl M; Kathryn M
    J Drugs Dermatol; 2006 May; 5(5):406-9. PubMed ID: 16703775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angioedema-Urticaria Due to Acitretin.
    Solak B; Metin N; Erdem MT
    Am J Ther; 2016; 23(4):e1116-7. PubMed ID: 26820109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acitretin induces capillary leak syndrome in a patient with pustular psoriasis.
    Vos LE; Vermeer MH; Pavel S
    J Am Acad Dermatol; 2007 Feb; 56(2):339-42. PubMed ID: 17097361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acitretin Use in Dermatology.
    Guenther LC; Kunynetz R; Lynde CW; Sibbald RG; Toole J; Vender R; Zip C
    J Cutan Med Surg; 2017; 21(3_suppl):2S-12S. PubMed ID: 28952335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repigmentation and curling of hair after acitretin therapy.
    Seckin D; Yildiz A
    Australas J Dermatol; 2009 Aug; 50(3):214-6. PubMed ID: 19659987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the efficacy of acitretin therapy for nail psoriasis.
    Tosti A; Ricotti C; Romanelli P; Cameli N; Piraccini BM
    Arch Dermatol; 2009 Mar; 145(3):269-71. PubMed ID: 19289755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The acitretin and methotrexate combination therapy for psoriasis vulgaris achieves higher effectiveness and less liver fibrosis.
    An J; Zhang D; Wu J; Li J; Teng X; Gao X; Li R; Wang X; Xia L; Xia Y
    Pharmacol Res; 2017 Jul; 121():158-168. PubMed ID: 28414177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acitretin-induced erythroderma in a psoriatic patient.
    Mahé E; Descamps V; Baïkian B; Toulon A; Crickx B
    J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1133-4. PubMed ID: 16987272
    [No Abstract]   [Full Text] [Related]  

  • 34. Acitretin combination therapy.
    Roenigk HH
    J Am Acad Dermatol; 1999 Sep; 41(3 Pt 2):S18-21. PubMed ID: 10459142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of systemic methotrexate vs. acitretin in psoriasis patients with significant palmoplantar involvement: a prospective, randomized study.
    Janagond AB; Kanwar AJ; Handa S
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e384-9. PubMed ID: 23066720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis.
    Choo W
    Int J Pharm Compd; 2016; 20(1):6-10. PubMed ID: 27125051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retinoids and phototherapy for psoriasis.
    Monfrecola G; Baldo A
    J Rheumatol Suppl; 2009 Aug; 83():71-2. PubMed ID: 19661548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative tolerability of systemic treatments for plaque-type psoriasis.
    McClure SL; Valentine J; Gordon KB
    Drug Saf; 2002; 25(13):913-27. PubMed ID: 12381213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-dose acitretin is associated with fewer adverse events than high-dose acitretin in the treatment of psoriasis.
    Pearce DJ; Klinger S; Ziel KK; Murad EJ; Rowell R; Feldman SR
    Arch Dermatol; 2006 Aug; 142(8):1000-4. PubMed ID: 16924049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acitretin-induced spiny follicular hyperkeratosis.
    Yanik ME; Erfan G; Albayrak H; Tasolar K; Albayrak S; Gelincik I; Kulac M
    Cutan Ocul Toxicol; 2016; 35(2):165-7. PubMed ID: 26340416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.